Professor in cancer genomics and tumor evolution at MD Anderson Cancer Center Visiting Group Leader at the Francis Crick Institute

Houston
Joined March 2019
NEW REVIEW ARTICLE @NatureCancer – “Aneuploidy and complex genomic rearrangements in cancer evolution” by @VanLooLab #TobyMBaker #SaraWaise #MaximeTarabichi. Read it here👇 nature.com/articles/s43018-0… rdcu.be/dxoLb
1
37
1
96
12,919
Today, @nature and @NatureMedicine are proud to publish amazing new insights into lung cancer evolution from the #TRACERx consortium. Updated collection: nature.com/collections/haffg… Great author threads👇
1
71
3
201
66,263
Peter Van Loo retweeted
How can we track cancer evolution using somatic copy-number alterations while considering whole-genome doubling events? With MEDICC2, now out in Genome Biology! schwarzlab.de/news#medicc2 doi.org/10.1186/s13059-022-0… bitbucket.org/schwarzlab/med…
3
25
78
Registration is now open for our Somatic Evolution and Tumour Microenvironment (SETM) symposium, where discussions and talks will focus on improving our understanding of cancer evolution. 📅 12 December 2022 🎟️ Free to attend online or in person ow.ly/4eqE50LgyVK
5
10
Peter Van Loo retweeted
We are delighted to announce Dr. Jonas Demeulemeester as a new group leader in the @VIBLifeSciences Center for Cancer Biology as of today where he will establish his Laboratory of Integrative Genomics. Welcome @zeunas at @vib_ccb!
15
11
2
97
Extremely honoured to share the (virtual) symposium floor with 11 other Emerging Leaders in @CompOncMSK and discuss their inspiring research! Thanks to @SohrabShah @PapaemmanuilLab @VanLooLab and of course @ATJCagan for capturing the moment.
2
4
53
CAMDAC: Copy number-Aware Methylation Deconvolution Analysis of Cancer live on GitHub at github.com/VanLoo-lab/CAMDAC! Run CAMDAC on tumour RRBS data & get tumour purity, allele-specific copy number and methylation rates free from normal contaminants. Preprint: tinyurl.com/y46zuvvw
9
1
27
Few days left to apply! Great project working on childhood leukaemia Closing date 18/5/21
We're recruiting for a bioinformatician to work on a precision oncology project integrating WGS, RNAseq, ATAC, drug testing and proteomics in childhood leukaemia . @uclcancer @Marcrmansour @WilliamsLabUCL @Dr_JB In collaboration with @VanLooLab Advert: bit.ly/3t5tb6e
9
9
Peter Van Loo retweeted
Excited to share new work @CD_AACR! bit.ly/3o2eWya Sophisticated background models in cancer genomics distinguish driver from passenger mutations. As most cancer DNA methylation changes are stochastic can we likewise create better models to identify driver events? 🪡 /n
13
59
5
218
Peter Van Loo retweeted
A large-scale snapshot of intratumor heterogeneity in human cancer dlvr.it/RxqMTK
2
62
1
203
Peter Van Loo retweeted
New Resource out now! A comprehensive annotation of intra-tumor #heterogeneity provides detailed insight into #tumor evolutionary #dynamics bit.ly/3x8TBrc @VanLooLab @TheCrick
Excited to share our new work published in @nature today by @darlanminussi @VanLooLab @HanghuiYe and Franziska michor on TNBC, in which we asked what happens after the initial burst of chromosome instability? nature.com/articles/s41586-0…
5
82
5
261
Happy New Year everyone! Check out this new Perspective from @theboutroslab @quaidmorris @VanLooLab on computational methods for cancer subclonal reconstruction, with recommendations for best practices for analyses and quality assessments. nature.com/articles/s41592-0…
Please join us for an afternoon of virtual talks on the 30th November starting at 12.30pm UK time: Somatic Evolution and Tumour Microenvironment Symposium 2020 crick.zoom.us/webinar/regist… 👌🙂
Peter Van Loo retweeted
Have been trying to suggest reading for new students - this is one of my favourites and pretty timeless jcs.biologists.org/content/1… Even after two decades, I still feel that I don’t know enough and understand little. And this makes me want to do research.
3
16
8
103
Peter Van Loo retweeted
(1/2) How much mRNA does a tumor cell produce and why does it matter? Our work led by @ShaolongCao and @JenniferWangMD finds that it’s an essential feature for tracking tumor phenotype. bit.ly/3cWq3n2
1
12
2
24